HIGHLIGHTS
- who: Fanglei Zuo from the Karolinska Institute Karolinska University, Ispra, Italy have published the research: Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
- future: The results suggest that this heterologous vaccination strategy may have advantageous in eliciting a broader immune_response although further investigations are required.
SUMMARY
Increasing evidence supports the notion that heterologous vaccination strategies like inactivated vaccines followed by a vector-based or an mRNA_vaccine, or a viral_vector-based vaccine followed by an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.